Addition of COMT-inhibitors to a LD/DDI regimen without concomitant individual adaption of LD/DDI intake by extension of dosing intervals or reduction of LD/DDI dosage may induce dyskinesia. Here, COMT is linked to drug-induced dyskinesia.